Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

DSpace Repository

Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

Author: Scholz, Alexander; Harter, Patrick N.; Cremer, Sebastian; Yalcin, Burak H.; Gurnik, Stefanie; Yamaji, Maiko; Di Tacchio, Mariangela; Sommer, Kathleen; Baumgarten, Peter; Baehr, Oliver; Steinbach, Joachim P.; Trojan, Joerg; Glas, Martin; Herrlinger, Ulrich; Krex, Dietmar; Meinhardt, Matthias; Weyerbrock, Astrid; Timmer, Marco; Goldbrunner, Roland; Deckert, Martina; Braun, Christian; Schittenhelm, Jens; Frueh, Jochen T.; Ullrich, Evelyn; Mittelbronn, Michel; Plate, Karl H.; Reiss, Yvonne
Tübinger Autor(en):
Braun, Christian
Schittenhelm, Jens Florian
Published in: Embo Molecular Medicine (2016), Bd. 8, H. 1, S. 39-57
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.15252/emmm.201505505
ISSN: 1757-4684
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)